Reklaim Ltd Renews Normal Course Issuer Bid to Repurchase Up to 10% of Public Float
MWN-AI** Summary
Reklaim Ltd. (TSXV: MYID) has announced the renewal of its Normal Course Issuer Bid (NCIB), which allows the company to repurchase up to 10% of its public float, equivalent to 13,053,580 common shares, based on the current total of 130,535,809 outstanding shares. The renewed NCIB will commence on February 17, 2026, and will last until February 11, 2027, unless the maximum number of shares is acquired sooner. Purchases will be executed at prevailing market prices in compliance with TSX Venture Exchange policies, with Integral Wealth Securities Limited managing the purchases.
Reklaim’s decision to initiate this NCIB is rooted in its belief that the current market price of its shares does not accurately reflect the intrinsic value of its consumer data privacy platform or the future growth prospects associated with its proprietary data assets. By allocating some of its cash flow toward share repurchases instead of seeking dilutive capital raises, Reklaim aims to demonstrate confidence in its long-term business model and capitalize on undervalued market conditions.
In the past 12 months, Reklaim has repurchased and canceled 209,000 shares at prices between $0.09 and $0.097 each. The company positions itself as a leader in consumer data privacy and monetization, enabling individuals to manage their personal data while offering brands and data partners compliant, consent-based data solutions.
Reklaim warns that its forward-looking statements regarding the NCIB and overall growth strategies carry risks and uncertainties that could lead to actual results differing materially from those projected. As a result, stakeholders are advised to exercise caution regarding reliance on these statements.
MWN-AI** Analysis
Reklaim Ltd.'s decision to renew its Normal Course Issuer Bid (NCIB) represents a strategic move aimed at underscoring its commitment to enhancing shareholder value amid current market valuations that may not reflect its true intrinsic worth. The company plans to repurchase up to 10% of its public float, which equates to approximately 13 million shares, signaling confidence in its consumer data privacy and monetization sector.
As observed, Reklaim's prior NCIB actions led to the repurchase of 209,000 shares at relatively modest prices, suggesting that the company is proactively managing its capital structure. By implementing the NCIB, Reklaim is positioning itself to utilize excess cash reserves to buy back shares instead of engaging in dilutive equity financing. This tactic can maintain stock price stability and potentially improve earnings per share over time, a significant indicator for investors.
Investors should note the issuance's rationale: a belief that current market prices may undervalue its proprietary data assets and foreseeable growth avenues. Such insights can be crucial when considering the timing and entry points for investment in Reklaim.
However, investors should approach these plans with caution. Although the initiative may bolster stock prices and investor sentiment in the near term, it does not guarantee long-term financial performance. Prospective investors should weigh forward-looking statements against potential market risks inherent in the data privacy sector, characterized by regulatory changes and competitive pressures.
Ultimately, Reklaim’s renewed NCIB could be a positive indicator for those considering an investment in the company. Still, careful attention to market conditions, strategic execution of the buyback, and broader industry trends will be vital for assessing the potential impact on shareholder value.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Canada NewsWire
Share NCIB repurchase program reflects confidence in Reklaim's consumer data privacy and monetization business
TORONTO, Feb. 11, 2026 /CNW/ - Reklaim Ltd. (TSXV: MYID) (OTC: MYIDF) ("Reklaim" or the "Company"), a consumer data privacy and data monetization platform, today announced that the TSX Venture Exchange (the "Exchange") has accepted its notice of intention to renew its Normal Course Issuer Bid ("NCIB").
Under the renewed NCIB, Reklaim may purchase for cancellation up to 13,053,580 common shares, representing 10% of its public float of 130,535,809 issued and outstanding common shares as of the date of the notice.
The NCIB will commence on February 17, 2026 and will terminate on the earlier of February 11, 2027, or the date on which the Company has acquired the maximum number of shares permitted under the NCIB.
Purchases will be made through the facilities of the TSX Venture Exchange at prevailing market prices, in accordance with Exchange policies. The Company has engaged Integral Wealth Securities Limited to conduct purchases on its behalf. All shares acquired under the NCIB will be cancelled.
Rationale for the NCIB
Reklaim believes the current market price of its shares may not fully reflect the intrinsic value of its consumer data privacy platform, proprietary data assets, and future growth opportunities.
Reklaim currently has the flexibility to allocate a portion of its cash flow toward share repurchases rather than raising dilutive capital. The Company views the NCIB as a prudent capital allocation tool when market conditions do not reflect the underlying value of its business.
Previous NCIB Activity
Over the past 12 months, Reklaim repurchased and cancelled a total of 209,000 common shares at prices ranging from approximately $0.09 to $0.097 per share.
About Reklaim Ltd.
Reklaim is a consumer data privacy and data monetization platform that enables individuals to view, control, delete, or monetize their personal data. Reklaim delivers privacy-compliant, consent-based data solutions to brands, agencies, and data partners while empowering consumers with transparency and control over their digital footprint.
For more information, visit:
https://www.reklaimyou.com/investors
Forward-Looking Statements
This news release contains forward-looking statements relating to the Company's NCIB, capital allocation strategy, and future growth. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update these statements except as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
SOURCE Reklaim Ltd.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2026/11/c3767.html
FAQ**
How does Reklaim Ltd's renewed NCIB for repurchasing Killi Ltd - Ordinary Shares MYIDF align with its overall strategy for enhancing shareholder value and capital allocation?
What specific market conditions led Reklaim Ltd to believe that the current price of Killi Ltd - Ordinary Shares MYIDF does not reflect its intrinsic value?
How does the engagement of Integral Wealth Securities Limited to execute the NCIB influence Reklaim Ltd's ability to manage the repurchase of Killi Ltd - Ordinary Shares MYIDF effectively?
Can Reklaim Ltd provide insights into the potential impact of the NCIB on its future growth and operational flexibility regarding Killi Ltd - Ordinary Shares MYIDF?
**MWN-AI FAQ is based on asking OpenAI questions about Reklaim Ltd. (TSXVC: MYID:CC).
NASDAQ: MYID:CC
MYID:CC Trading
0.0% G/L:
$0.08 Last:
7,800 Volume:
$0.08 Open:



